Sec Form 4 Filing - Versant Ventures III, LLC @ Flexion Therapeutics Inc - 2016-06-08

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Versant Ventures III, LLC
2. Issuer Name and Ticker or Trading Symbol
Flexion Therapeutics Inc [ FLXN]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
ONE SANSOME STREET, SUITE 3630
3. Date of Earliest Transaction (MM/DD/YY)
06/08/2016
(Street)
SAN FRANCISCO, CA94104
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/08/2016 P 710,091 A $ 14 3,511,670 I See Footnote ( 1 )
Common Stock 06/08/2016 P 4,194 A $ 14 20,739 I See Footnote ( 2 )
Common Stock 388,683 I See Footnote ( 3 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Versant Ventures III, LLC
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Venture Capital III, L.P.
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Side Fund III, L.P.
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Development Fund III, L.P.
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO, CA94104
X
ATWOOD BRIAN G
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO, CA94104
X
COLELLA SAMUEL D
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO, CA94104
X
JAFFE ROSS A MD
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO, CA94104
X
LINK WILLIAM J PHD
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO, CA94104
X
MILDER DONALD B
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO, CA94104
X
ROBERTSON REBECCA B
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO, CA94104
X
Signatures
Versant Ventures III, LLC 06/10/2016
Signature of Reporting Person Date
Versant Venture Capital III, L.P. 06/10/2016
Signature of Reporting Person Date
Versant Side Fund III, L.P. 06/10/2016
Signature of Reporting Person Date
Versant Development Fund III, LLC 06/10/2016
Signature of Reporting Person Date
Brian G. Atwood By: Robin L. Praeger as attorney-in-fact 06/10/2016
Signature of Reporting Person Date
Samuel D. Colella By: Robin L. Praeger as attorney-in-fact 06/10/2016
Signature of Reporting Person Date
Ross A. Jaffe, MD By: Robin L. Praeger as attorney-in-fact 06/10/2016
Signature of Reporting Person Date
William J. Link, MD By: Robin L. Praeger as attorney-in-fact 06/10/2016
Signature of Reporting Person Date
Donald B. Milder By: Robin L. Praeger as attorney-in-fact 06/10/2016
Signature of Reporting Person Date
Rebecca B. Robertson By: Robin L. Praeger as attorney-in-fact 06/10/2016
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The shares are held by Versant Venture Capital III, L.P. ("VVC III"). Versant Ventures III, LLC, a Delaware limited liability company ("VV III") serves as the sole general partner of VVC III. Brian G. Atwood, Ross A. Jaffe, M.D., Samuel D. Colella, Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Ph.D., William J. Link, Ph.D., Charles M. Warden, Robin L. Praeger and Barbara N. Lubash are managing directors and/or members of VV III and share voting and dispositive power over the shares held by VVC III; however, they disclaim beneficial ownership of the shares held by such entities except to the extent of their pecuniary interests therein. Samuel D. Colella is a director of the Issuer and, accordingly, files separate Section 16 reports.
( 2 )The shares are held by Versant Side Fund III, L.P. ("VSF III"). VV III serves as the sole general partner of VSF III. Brian G. Atwood, Ross A. Jaffe, M.D., Samuel D. Colella, Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Ph.D., William J. Link, Ph.D., Charles M. Warden, Robin L. Praeger and Barbara N. Lubash are managing directors and/or members of VV III and share voting and dispositive power over the shares held by VSF III; however, they disclaim beneficial ownership of the shares held by such entities except to the extent of their pecuniary interests therein. Samuel D. Colella is a director of the Issuer and, accordingly, files separate Section 16 reports.
( 3 )The shares are held by Versant Development Fund III, LLC ("Development III"). Brian G. Atwood, Ross A. Jaffe, M.D., Samuel D. Colella, Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Ph.D., William J. Link, Ph.D., Charles M. Warden, Robin L Praeger and Barbara N. Lubash are managing directors and/or members of VV III and share voting and investment authority over the shares held by Development III; however, they disclaim beneficial ownership of the shares held by such entities except to the extent of their pecuniary interests therein. Samuel D. Colella is a director of the Issuer and, accordingly, files separate Section 16 reports.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.